TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05041842 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05041842 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05549505 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06582862 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study NCT06582862 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study NCT06582862 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT06582862 — Safety Biomarker (SAF): Succinate dehydrogenase
Genes: SDHD
Study NCT06582121 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study NCT06435689 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06435689 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT01169792 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT01169792 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT01169792 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT04481555 — Predictive Biomarker (PRD): LAMA1 mRNA
Genes: LAMA1; LAMA
Study NCT05768321 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05097664 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05765838 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06332014 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05613504 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06020144 — Predictive Biomarker (PRD): TLL1 mRNA
Genes: TLL1; TLL
Study NCT05444894 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT05309018 — Safety Biomarker (SAF): Aminopeptidase N
Genes: ANPEP; APN; CD13; PEPN
Study NCT05249309 — Predictive Biomarker (PRD): SIRT3 mRNA
Genes: SIRT3; SIR2L3
Study NCT05249309 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05188547 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06054035 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04648111 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04648111 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05975528 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04902196 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06136910 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06136910 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05298410 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05848791 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06438705 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT06087848 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT06087848 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT04825912 — Predictive Biomarker (PRD): SST mRNA
Genes: SST
Study NCT01215474 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05217290 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04875351 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04875351 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06583213 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05635487 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05529134 — Predictive Biomarker (PRD): COL7A1 mRNA
Genes: COL7A1
Study NCT05956327 — Predictive Biomarker (PRD): CA4 mRNA
Genes: CA4
Study NCT06499532 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05146830 — Predictive Biomarker (PRD): CTNS mRNA
Genes: CTNS
Study NCT05215418 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05780060 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04683679 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04931979 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT04772313 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT00172276 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05017168 — Predictive Biomarker (PRD): TP63 mRNA
Genes: TP63; KET; P63; P73H; P73L; TP73L
Study NCT05636267 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05636267 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06128408 — Predictive Biomarker (PRD): TRO mRNA
Genes: TRO; KIAA1114; MAGED3
Study NCT06277024 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05781256 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04338360 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04994405 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06036186 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04993755 — Pharmacodynamic Biomarker (PDY): Guanine nucleotide exchange factor C9orf72
Genes: C9orf72; DENND9; DENNL72
Study NCT05089188 — Predictive Biomarker (PRD): PRAME mRNA
Genes: PRAME; MAPE; OIP4
Study NCT06222931 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04770740 — Predictive Biomarker (PRD): MGP mRNA
Genes: MGP; MGLAP; GIG36
Study NCT04770740 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT05085444 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05085444 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT04949412 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05222997 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06582979 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06029543 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT05149391 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05149391 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT05892822 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT06009276 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05002036 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05853432 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05853432 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05135468 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT05748587 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT04603326 — Pharmacodynamic Biomarker (PDY): Leucine-rich repeat kinase 2
Genes: LRRK2; PARK8
Study NCT05796076 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04748471 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05616793 — Predictive Biomarker (PRD): LCA5 mRNA
Genes: LCA5; C6orf152
Study NCT06529471 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00614640 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04665986 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01194401 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06142474 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT00002376 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04789837 — Predictive Biomarker (PRD): SOCS3 mRNA
Genes: SOCS3; CIS3; SSI3
Study NCT04789837 — Safety Biomarker (SAF): Interleukin 1
Study NCT04703595 — Predictive Biomarker (PRD): RFC1 mRNA
Genes: RFC1; RFC140
Study NCT04682392 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05430646 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT06022068 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05547633 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05547633 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05582798 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT00062530 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04943133 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06581744 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT04800133 — Surrogate Endpoint (SUR): Neutralizing antibody response
Study NCT04800133 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05446779 — Safety Biomarker (SAF): CYP11B1 mRNA
Genes: CYP11B1; S11BH
Study NCT06272721 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT05747105 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04051346 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT04816643 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05590364 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06429293 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06333418 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06581900 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT04957823 — Predictive Biomarker (PRD): FNDC5 mRNA
Genes: FNDC5; FRCP2
Study NCT05148091 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05463640 — Predictive Biomarker (PRD): ADGRE2 mRNA
Genes: ADGRE2; EMR2
Study NCT06193616 — Surrogate Endpoint (SUR): Total kidney volume
Study NCT05492643 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06458465 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06388005 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05813860 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05977192 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05965752 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04975204 — Predictive Biomarker (PRD): BAK1 mRNA
Genes: BAK1; BAK; BCL2L7; CDN1
Study NCT04975204 — Predictive Biomarker (PRD): BAX mRNA
Genes: BAX; BCL2L4
Study NCT04975204 — Predictive Biomarker (PRD): BAD mRNA
Genes: BAD; BBC6; BCL2L8
Study NCT04975204 — Safety Biomarker (SAF): Cytochrome c
Study NCT00000947 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04922723 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT06281964 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05211648 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06031558 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT06331169 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06331169 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05373108 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT06241638 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05814731 — Predictive Biomarker (PRD): ELN mRNA
Genes: ELN
Study NCT06081478 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06081478 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT05311189 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06582797 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT06387420 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study NCT05184452 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06094881 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT05667376 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT06218628 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT06218628 — Predictive Biomarker (PRD): JAK2
Genes: JTK10
Study NCT05560607 — Predictive Biomarker (PRD): HSD17B13 mRNA
Genes: HSD17B13; SCDR9; SDR16C3; HMFN0376; UNQ497/PRO1014
Study NCT05083026 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06551285 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06551285 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06551285 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05156671 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study NCT04671589 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT04686929 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT06341816 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT04632225 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT04521894 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05038878 — Surrogate Endpoint (SUR): Urine free cortisol
Study NCT06294717 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06460480 — Predictive Biomarker (PRD): NRGN mRNA
Genes: NRGN
Study NCT06551597 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06217913 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05637216 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study NCT05080296 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT06307314 — Predictive Biomarker (PRD): SAA1 mRNA
Genes: SAA1
Study NCT06025071 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06025071 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05191004 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05191004 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05191004 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05191004 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06414616 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06132373 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT05190445 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00002100 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06272565 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT06272565 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06272565 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05966584 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT05966584 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT05966584 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06203613 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT05066360 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT04708704 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT05832203 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05978401 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study NCT06551155 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04747470 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT05457504 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04944173 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04835857 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05647577 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05081037 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06325826 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study NCT05957328 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05074368 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05740111 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study NCT05740111 — Safety Biomarker (SAF): Serine/threonine-protein kinase STK11
Genes: STK11
Study NCT05740111 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT05740111 — Predictive Biomarker (PRD): PRSS1 mRNA
Genes: PRSS1; TRP1; TRY1; TRYP1
Study NCT05740111 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05454241 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT06020118 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05976906 — Predictive Biomarker (PRD): KLRK1 mRNA
Genes: KLRK1; D12S2489E; NKG2D
Study NCT05393895 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05468580 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study NCT06220188 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06298838 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05488106 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05004389 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05004389 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05004389 — Safety Biomarker (SAF): BDNF
Study NCT05004389 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05495776 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT05942872 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04682912 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study NCT04991246 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05302960 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04873895 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04873895 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05509530 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05509530 — Predictive Biomarker (PRD): GPRC5D mRNA
Genes: GPRC5D
Study NCT06182644 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT05809726 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05529862 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05529862 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05529862 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05529862 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05612581 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04936737 — Predictive Biomarker (PRD): CARNS1 mRNA
Genes: CARNS1; ATPGD1; KIAA1394
Study NCT04936737 — Predictive Biomarker (PRD): CNDP2 mRNA
Genes: CNDP2; CN2; CPGL; HEL-S-13; PEPA
Study NCT04993430 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05238844 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04653727 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06484608 — Surrogate Endpoint (SUR): Serum sodium
Study NCT06411106 — Predictive Biomarker (PRD): TLR7 mRNA
Genes: TLR7; UNQ248/PRO285
Study NCT05130489 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04971187 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05126550 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05098249 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT05375656 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT04614194 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05348564 — Predictive Biomarker (PRD): KCNQ1 mRNA
Genes: KCNQ1; KCNA8; KCNA9; KVLQT1
Study NCT05348564 — Predictive Biomarker (PRD): APOB mRNA
Genes: APOB
Study NCT05518994 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05881824 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04742764 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04742764 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT04742764 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04268706 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT05637073 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT05129111 — Pharmacodynamic Biomarker (PDY): Salivary secretion
Study NCT06282302 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04752228 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05268601 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05637541 — Monitoring Biomarker (MOI): HBV DNA
Study NCT06235229 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06235229 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05297292 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06416865 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05648006 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05825365 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT04728880 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05068726 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05747768 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT05747768 — Predictive Biomarker (PRD); Safety Biomarker (SAF): ABCG2
Genes: EST157481; MXR; BCRP; ABCP; CD338
Study NCT05867706 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05867706 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04337112 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05749276 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38